NEOMIDES Trademark

Trademark Overview


On Tuesday, September 20, 2022, a trademark application was filed for NEOMIDES with the United States Patent and Trademark Office. The USPTO has given the NEOMIDES trademark a serial number of 79370155. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by KANGPU BIOPHARMACEUTICALS, LTD.. The NEOMIDES trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Demonstration of goods; advertising services; business management assistance; market research studies; commercial administration of the licensing of the goods and services of others; organization of exhibitions for commercial or advertising purposes; provision of an on-line marketplace for buyers and sellers of goods and services; import-export agency services; systemization of information into computer databases; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale drug store services; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring medical supplies

Technological research in the field of pharmaceutical, veterinary and sanitary preparations; scientific research; research and development of new products for others; cancer research for medical purposes in the area of cancerous diseases; quality control for others; chemistry services, namely, laboratory research and analysis in the field of chemistry; chemical research; medical research; medical and scientific research, namely, conducting clinical trials for others; bacteriological research; biological research; conducting early medical evaluations in the field of new pharmaceutical drugs and conducting early medical evaluations in the field of the implementation of new pharmaceutical drugs; laboratory research in the field of pharmaceutical drug evaluation; scientific research in the field of pharmaceutical drug evaluation; pharmaceutical drug product evaluation; pharmaceutical drug research; laboratory pharmaceutical drug testing; scientific research in the field of pharmaceutical d...
neomides

General Information


Serial Number79370155
Word MarkNEOMIDES
Filing DateTuesday, September 20, 2022
Status700 - REGISTERED
Status DateTuesday, May 28, 2024
Registration Number7394310
Registration DateTuesday, May 28, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Pseudo MarkNEO MIDES
Goods and ServicesDemonstration of goods; advertising services; business management assistance; market research studies; commercial administration of the licensing of the goods and services of others; organization of exhibitions for commercial or advertising purposes; provision of an on-line marketplace for buyers and sellers of goods and services; import-export agency services; systemization of information into computer databases; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale drug store services; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring medical supplies
Goods and ServicesTechnological research in the field of pharmaceutical, veterinary and sanitary preparations; scientific research; research and development of new products for others; cancer research for medical purposes in the area of cancerous diseases; quality control for others; chemistry services, namely, laboratory research and analysis in the field of chemistry; chemical research; medical research; medical and scientific research, namely, conducting clinical trials for others; bacteriological research; biological research; conducting early medical evaluations in the field of new pharmaceutical drugs and conducting early medical evaluations in the field of the implementation of new pharmaceutical drugs; laboratory research in the field of pharmaceutical drug evaluation; scientific research in the field of pharmaceutical drug evaluation; pharmaceutical drug product evaluation; pharmaceutical drug research; laboratory pharmaceutical drug testing; scientific research in the field of pharmaceutical drug testing; pharmaceutical drug development services; pharmaceutical drug research and development; medical and pharmaceutical drug research services; pharmaceutical research services; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; laboratory research in the field of pharmaceutical drug detection; scientific research in the field of pharmaceutical drug detection; material testing; software as a service (SaaS) featuring software for use in database management, collecting and analyzing medical and scientific data

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, May 26, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 26, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKANGPU BIOPHARMACEUTICALS, LTD.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCN

Party NameKANGPU BIOPHARMACEUTICALS, LTD.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCN

Party NameKANGPU BIOPHARMACEUTICALS, LTD.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCN

Trademark Events


Event DateEvent Description
Thursday, May 25, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 30, 2023APPLICATION FILING RECEIPT MAILED
Friday, June 30, 2023ASSIGNED TO EXAMINER
Friday, June 30, 2023NON-FINAL ACTION WRITTEN
Saturday, July 1, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 7, 2023REFUSAL PROCESSED BY MPU
Tuesday, August 8, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, August 29, 2023REFUSAL PROCESSED BY IB
Friday, January 26, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 26, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 31, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 31, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 31, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 21, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024NOTIFICATION PROCESSED BY IB
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 28, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, August 28, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB